FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091162 [Registered on: 18/07/2025] Trial Registered Prospectively
Last Modified On: 16/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   A study on clinical features , hormonal levels and genetic causes in individuals with atypical genitalia 
Scientific Title of Study   Clinical,Biochemical,genetic profile and gender identity pattern in Disorders of sex development 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aravind kumar 
Designation  Post Graduate in DM Endocrinology 
Affiliation  Madurai Medical college 
Address  9,Machendra bhavanam, Maruthupandiar 1st street, Pasumpon nagar,Palanganatham,Madurai

Madurai
TAMIL NADU
625003
India 
Phone  09384337260  
Fax    
Email  aravindkumar1175@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR.S.SRIDHAR 
Designation  Professor and HOD ,Department of Endocrinology 
Affiliation  Madurai Medical college 
Address  Department of Endocrinology,Madurai Medical College and Government Rajaji Hospital,Madurai

Madurai
TAMIL NADU
625020
India 
Phone  9789720246  
Fax    
Email  drsridharjipmer@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Aravind kumar 
Designation  Post Graduate in DM Endocrinology 
Affiliation  Madurai Medical college 
Address  9,Machendra bhavanam, Maruthupandiar 1st street, Pasumpon nagar,Palanganatham,Madurai

Madurai
TAMIL NADU
625003
India 
Phone  09384337260  
Fax    
Email  aravindkumar1175@gmail.com  
 
Source of Monetary or Material Support  
Department of Endocrinology,Madurai Medical College,Government Rajaji Hospital,Madurai -625020 
 
Primary Sponsor  
Name  Department Of Endocrinology 
Address  Madurai Medical College,MADURAI,TAMILNADU,India-625020 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aravind kumar  DEPARTMENT OF ENDOCRINOLOGY,GOVERNMENT RAJAJI HOSPITAL MADURAI.OP NO -18  Panagal road,Gorpalayam,Madurai-625002
Madurai
TAMIL NADU 
09384337260

aravindkumar1175@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE,MADURAI MEDICAL COLLEGE,MADURAI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E349||Endocrine disorder, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  60.00 Year(s)
Gender  Both 
Details  46 XX and 46 XY DSD with genital ambiguity,proximal or midshaft hypospadias,Apparent female genitalia with clitoromegaly,Female phenotype with primary amenorrhoea,Children with inguinal or labial mass,Posterior labial fusion and common urogenital sinus 
 
ExclusionCriteria 
Details  Sex chromosomal DSD like Turner syndrome and Klinefelter syndrome.
Ambiguous genitalia due to maternal androgen exposure ,maternal virilizing ovarian or adrenal tumour 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To identify proportion of patients in whom a pathogenic or likely pathogennic variant is idenitfied explaining the DSD phenotype  Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
To find any discrepancy in assigned gender at birth & gender identity pattern in adolescense
 
Baseline 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Other (Terminated) 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To study clinical and biochemical parameters in patients with Disorders of sex development and correlate them with genetic analysis and find discrepancies if any.This could help in more accurate diagnosis and gender assignment . Early appropriate diagnosis would aid in  future therapies and genetic counselling . 
Close